Oteseconazole

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status
Oteseconazole 1340593-59-0 Aug, 2026  Apr.22, 2031 estimated PV Completion – Jun, 2026

 

[Indication]

For the prevention of recurrent vulvovaginal candidiasis (RVVC) in females who are not of reproductive potential.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us